These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 34632544)
1. MicroRNA-324-3p Plays A Protective Role Against Coxsackievirus B3-Induced Viral Myocarditis. Liu T; Tong J; Shao C; Qu J; Wang H; Shi Y; Lin Y; Liu Y; Shao S; Shen H Virol Sin; 2021 Dec; 36(6):1585-1599. PubMed ID: 34632544 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA. Rani P; George B; V S; Biswas S; V M; Pal A; Rajmani RS; Das S J Virol; 2024 Feb; 98(2):e0150423. PubMed ID: 38289119 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis. Zhou L; He X; Gao B; Xiong S J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-30a Modulates Type I Interferon Responses to Facilitate Coxsackievirus B3 Replication Li J; Xie Y; Li L; Li X; Shen L; Gong J; Zhang R Front Immunol; 2020; 11():603437. PubMed ID: 33519812 [TBL] [Abstract][Full Text] [Related]
5. The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis. Corsten MF; Heggermont W; Papageorgiou AP; Deckx S; Tijsma A; Verhesen W; van Leeuwen R; Carai P; Thibaut HJ; Custers K; Summer G; Hazebroek M; Verheyen F; Neyts J; Schroen B; Heymans S Eur Heart J; 2015 Nov; 36(42):2909-19. PubMed ID: 26206211 [TBL] [Abstract][Full Text] [Related]
6. Engineered coxsackievirus B3 containing multiple organ-specific miRNA targets showed attenuated viral tropism and protective immunity. Xiao Z; He F; Feng M; Liu Z; Liu Z; Li S; Wang W; Yao H; Wu J Infect Genet Evol; 2022 Sep; 103():105316. PubMed ID: 35718333 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-425-3p inhibits myocardial inflammation and cardiomyocyte apoptosis in mice with viral myocarditis through targeting TGF-β1. Li J; Tu J; Gao H; Tang L Immun Inflamm Dis; 2021 Mar; 9(1):288-298. PubMed ID: 33332750 [TBL] [Abstract][Full Text] [Related]
8. LncRNA XIST knockdown reduces myocardial damage in myocarditis by targeting the miR-140-3p/RIPK1 axis. Zhang Z; Zhu D; Shi P; Wu J; Li F; Chen Y Biotechnol Genet Eng Rev; 2024 Nov; 40(3):1425-1437. PubMed ID: 36971142 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-203 enhances coxsackievirus B3 replication through targeting zinc finger protein-148. Hemida MG; Ye X; Zhang HM; Hanson PJ; Liu Z; McManus BM; Yang D Cell Mol Life Sci; 2013 Jan; 70(2):277-91. PubMed ID: 22842794 [TBL] [Abstract][Full Text] [Related]
10. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice. He F; Yao H; Wang J; Xiao Z; Xin L; Liu Z; Ma X; Sun J; Jin Q; Liu Z J Virol; 2015 Jan; 89(2):908-16. PubMed ID: 25339771 [TBL] [Abstract][Full Text] [Related]
11. The protective role of microRNA-21 against coxsackievirus B3 infection through targeting the MAP2K3/P38 MAPK signaling pathway. He F; Xiao Z; Yao H; Li S; Feng M; Wang W; Liu Z; Liu Z; Wu J J Transl Med; 2019 Oct; 17(1):335. PubMed ID: 31585536 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of microRNA-15 protects H9c2 cells against CVB3-induced myocardial injury by targeting NLRX1 to regulate the NLRP3 inflammasome. Tong R; Jia T; Shi R; Yan F Cell Mol Biol Lett; 2020; 25():6. PubMed ID: 32099552 [TBL] [Abstract][Full Text] [Related]
13. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas. Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635 [TBL] [Abstract][Full Text] [Related]
14. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis. Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012 [TBL] [Abstract][Full Text] [Related]
15. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication. Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210 [TBL] [Abstract][Full Text] [Related]
16. Cardiac miR-19a/19b was induced and hijacked by CVB3 to facilitate virus replication via targeting viral genomic RdRp-encoding region. Wu Y; Yue Y; Xiong S Antiviral Res; 2023 Sep; 217():105702. PubMed ID: 37604350 [TBL] [Abstract][Full Text] [Related]
17. Altered exosomal miR-181d and miR-30a related to the pathogenesis of CVB3 induced myocarditis by targeting SOCS3. Fan KL; Li MF; Cui F; Feng F; Kong L; Zhang FH; Hao H; Yin MX; Liu Y Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2208-2215. PubMed ID: 30915768 [TBL] [Abstract][Full Text] [Related]
18. Antiviral and myocyte protective effects of IL-28A in coxsackievirus B3-induced myocarditis. Wang S; Huang X; Zhang J; Huang C Braz J Infect Dis; 2015; 19(2):132-40. PubMed ID: 25528576 [TBL] [Abstract][Full Text] [Related]
19. MiR-223/Pknox1 axis protects mice from CVB3-induced viral myocarditis by modulating macrophage polarization. Gou W; Zhang Z; Yang C; Li Y Exp Cell Res; 2018 May; 366(1):41-48. PubMed ID: 29524390 [TBL] [Abstract][Full Text] [Related]
20. MiR-21 confers resistance against CVB3-induced myocarditis by inhibiting PDCD4-mediated apoptosis. He J; Yue Y; Dong C; Xiong S Clin Invest Med; 2013 Apr; 36(2):E103-11. PubMed ID: 23544605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]